Sanofi Reports Positive Results From Messenger RNA Respiratory Vaccine Trials
French pharmaceutical company Sanofi has announced strong late-stage clinical trial results for a messenger RNA vaccine targeting a broad range of respiratory viruses. The company expects European regulatory review by the end of the year, with potential commercial opportunities in preventative healthcare.